139 related articles for article (PubMed ID: 29130573)
21. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
[TBL] [Abstract][Full Text] [Related]
22. Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study).
D'Ascenzo F; Omedè P; De Filippo O; Cerrato E; Autelli M; Trabattoni D; Ryan N; Venuti G; Muscoli S; Montabone A; Wojakowski W; Rognoni A; Helft G; Gallo D; Parma R; De Luca L; Figini F; Mitomo S; Boccuzzi G; Mattesini A; Wańha W; Smolka G; Huczek Z; Cortese B; Sheiban I; Escaned J; Biolè C; Conrotto F; Templin C; Quadri G; Rolfo C; Capodanno D; Chieffo A; Nuñez-Gil I; Morbiducci U; Iannaccone M; Gili S; Mario CD; Moretti C; D'Amico M; Varbella F; Romeo F; Lüscher TF
Am J Cardiol; 2019 May; 123(10):1610-1619. PubMed ID: 30846212
[TBL] [Abstract][Full Text] [Related]
23. Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents.
Gili S; D'Ascenzo F; Di Summa R; Conrotto F; Cerrato E; Chieffo A; Boccuzzi G; Montefusco A; Ugo F; Omedé P; Kawamoto H; Tomassini F; Pavani M; Varbella F; Garbo R; D'Amico M; Biondi Zoccai G; Moretti C; Escaned J; Colombo A; Gaita F
Am J Cardiol; 2017 Jul; 120(1):33-39. PubMed ID: 28487035
[TBL] [Abstract][Full Text] [Related]
24. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
[TBL] [Abstract][Full Text] [Related]
25. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
26. Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.
Kufner S; Joner M; Thannheimer A; Hoppmann P; Ibrahim T; Mayer K; Cassese S; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
Circulation; 2019 Jan; 139(3):325-333. PubMed ID: 30586724
[TBL] [Abstract][Full Text] [Related]
27. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
[TBL] [Abstract][Full Text] [Related]
28. Comparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease: The Milan and New-Tokyo Registry.
Takagi K; Naganuma T; Chieffo A; Fujino Y; Latib A; Tahara S; Ishiguro H; Montorfano M; Carlino M; Kawamoto H; Kurita N; Hozawa K; Nakamura S; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27810964
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
van Zandvoort LJC; van Bommel RJ; Masdjedi K; Tovar Forero MN; Lemmert MM; Wilschut J; Diletti R; de Jaegere PPT; Zijlstra F; van Mieghem NM; Daemen J
Catheter Cardiovasc Interv; 2020 May; 95(6):1085-1091. PubMed ID: 31301161
[TBL] [Abstract][Full Text] [Related]
30. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
Migliorini A; Valenti R; Parodi G; Vergara R; Buonamici P; Cerisano G; Carrabba N; Antoniucci D
JACC Cardiovasc Interv; 2016 May; 9(10):1001-7. PubMed ID: 27198680
[TBL] [Abstract][Full Text] [Related]
31. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
[TBL] [Abstract][Full Text] [Related]
32. Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
Cherradi R; Ouldzein H; Zouaoui W; Elbaz M; Puel J; Carrié D
Arch Cardiovasc Dis; 2008 Jan; 101(1):11-7. PubMed ID: 18391867
[TBL] [Abstract][Full Text] [Related]
33. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
Uchida T; Popma J; Stone GW; Ellis SG; Turco MA; Ormiston JA; Muramatsu T; Nakamura M; Nanto S; Yokoi H; Baim DS
JACC Cardiovasc Interv; 2010 Apr; 3(4):403-11. PubMed ID: 20398868
[TBL] [Abstract][Full Text] [Related]
34. Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial.
De Filippo O; Bianco M; Tebaldi M; Iannaccone M; Gaido L; Guiducci V; Santarelli A; Zaccaro L; Depaoli A; Vaudano P; Quadri G; Gagnor A; Boccuzzi G; Solitro F; Cortese G; Guarnaccia C; Tore D; Veltri A; Franchin L; Angelini F; Garbo R; Giammaria M; Varbella F; Marchisio F; Fonio P; De Ferrari GM; Cerrato E; Campo G; D'Ascenzo F
Open Heart; 2020 Oct; 7(2):. PubMed ID: 33122421
[TBL] [Abstract][Full Text] [Related]
35. Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.
Gil RJ; Bil J; Džavík V; Vassilev D; Kern A; Formuszewicz R; Zalewska-Adamiec M; Dobrzycki S
Can J Cardiol; 2015 May; 31(5):671-8. PubMed ID: 25828372
[TBL] [Abstract][Full Text] [Related]
36. Long-term results after PCI of unprotected distal left main coronary artery stenosis: the Bifurcations Bad Krozingen (BBK)-Left Main Registry.
Ferenc M; Banholzer N; Hochholzer W; Mashayekhi K; Comberg T; Rothe J; Valina CM; Toma A; Löffelhardt N; Gick M; Neumann FJ; Nührenberg TG
Clin Res Cardiol; 2019 Feb; 108(2):175-184. PubMed ID: 30051181
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
38. Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease.
Sheiban I; Gerasimou A; Bollati M; Biondi-Zoccai G; Sciuto F; Omedé P; Sillano D; Trevi GP; Moretti C
Catheter Cardiovasc Interv; 2009 Jan; 73(1):25-31. PubMed ID: 19089932
[TBL] [Abstract][Full Text] [Related]
39. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
